The UK clinical eye research strategy: refreshing research priorities for clinical eye research in the UK.

Autor: Bourne RRA; Vision and Eye Research Institute, School of Medicine, Anglia Ruskin University, Cambridge, UK. rb@rupertbourne.co.uk.; Department of Ophthalmology, Cambridge University Hospitals, Cambridge, UK. rb@rupertbourne.co.uk., Moledina M; Imperial College NHS Foundation Trust, London, UK., Azuara-Blanco A; Centre for Public Health, Queen's University Belfast, Belfast, UK., Saleh GM; Research, Cataract and Adnexal Dept, Moorfields Eye Hospital, London, UK., Self JE; University of Southampton, Southampton, UK., Sivaprasad S; NIHR Moorfields Clinical Research Facility, Moorfields Eye Hospital, London, UK., Sharma SM; Dept of Ophthalmology, Oxford Eye Hospital, Oxford University Hospitals NHS Trust, Oxford, UK., Ross A; Department of Ophthalmology, Cambridge University Hospitals, Cambridge, UK.; Aswan University Hospital, Aswan, Egypt., Gilbert RM; Department of Ophthalmology, Cambridge University Hospitals, Cambridge, UK., Abdalla Elsayed MEA; Dept of Ophthalmology, Oxford Eye Hospital, Oxford University Hospitals NHS Trust, Oxford, UK., Moon WY; Dept of Ophthalmology, Oxford Eye Hospital, Oxford University Hospitals NHS Trust, Oxford, UK., Doug M; Vision and Eye Research Institute, School of Medicine, Anglia Ruskin University, Cambridge, UK., Mulholland PJ; NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.; Centre for Optometry & Vision Sciences, School of Biomedical Sciences, Ulster University, Coleraine, Northern Ireland, UK., Day AC; NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK., Romano V; Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy., Hoad GV; Macular Society, Andover, UK., Kara M; Fight for Sight, London, UK., Murray A; Moorfields Eye Charity, Moorfields Eye Hospital, London, UK., Gow L; Eye care and living well services, Royal National Institute of Blind people, London, UK., Ghanchi F; Bradford Teaching Hospitals, Royal Infirmary, Bradford, West Yorkshire, UK., Patel PJ; NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK., Gale RP; York Hospital, University of York, York, UK., Dinah C; Department of Ophthalmology, London North West University Healthcare NHS Trust, London, UK.; Brain Sciences, Imperial College London, London, UK., Valentine K; Fight for Sight, London, UK., Yelf C; Macular Society, Andover, UK., Poustie V; NIHR Clinical Research Network, University of Liverpool, Liverpool, UK.

Publikováno v: Eye (London, England) [Eye (Lond)] 2024 Jul; Vol. 38 (10), pp. 1947-1957. Date of Electronic Publication: 2024 May 29.

Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular Degeneration.

Autor: Rodrigues IA; International Consortium for Health Outcomes Measurement, Boston, Massachusetts; Department of Ophthalmology, St Thomas' Hospital, London, United Kingdom., Sprinkhuizen SM; International Consortium for Health Outcomes Measurement, Boston, Massachusetts., Barthelmes D; Department of Ophthalmology, University Hospital Zurich, and the University of Zurich, Zurich, Switzerland; The Save Sight Institute, The University of Sydney, Sydney, Australia., Blumenkranz M; Byers Eye Institute, Stanford University, Palo Alto, California., Cheung G; Singapore National Eye Center, Singapore., Haller J; Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania., Johnston R; Gloucestershire Hospitals NHS Foundation Trust, Gloucester, United Kingdom., Kim R; Aravind Eye Hospital, Madurai, India., Klaver C; Erasmus Medical Center, Rotterdam, Netherlands., McKibbin M; Royal College of Ophthalmologists, London, United Kingdom., Ngah NF; Hospital Selayang, Selangor, Malaysia., Pershing S; Byers Eye Institute, Stanford University, Palo Alto, California; Veterans Affairs Palo Alto Health Care System, Livermore, California., Shankar D; International Consortium for Health Outcomes Measurement, Boston, Massachusetts., Tamura H; Department of Ophthalmology & Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan; Division of Medical Information Technology & Administration Planning, Kyoto University Hospital, Kyoto, Japan., Tufail A; Moorfields Eye Hospital, London, United Kingdom., Weng CY; Baylor College of Medicine, Houston, Texas., Westborg I; Umeå University, Registercenter Syd/EyeNet Sweden, Karlskrona, Sweden., Yelf C; Macular Society, Andover, United Kingdom., Yoshimura N; Department of Ophthalmology & Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan., Gillies MC; The Save Sight Institute, The University of Sydney, Sydney, Australia. Electronic address: mark.gillies@sydney.edu.au.

Publikováno v: American journal of ophthalmology [Am J Ophthalmol] 2016 Aug; Vol. 168, pp. 1-12. Date of Electronic Publication: 2016 Apr 27.

Review of Retinal Imaging Modalities for Hydroxychloroquine Retinopathy.

Autor: Cheong, Kai Xiong¹ (AUTHOR), Ong, Charles Jit Teng¹ (AUTHOR), Chandrasekaran, Priya R¹ (AUTHOR), Zhao, Jinzhi¹ (AUTHOR), Teo, Kelvin Yi Chong^1,2 (AUTHOR), Mathur, Ranjana^1,2 (AUTHOR) ranjana.mathur@singhealth.com.sg

Publikováno v: Diagnostics (2075-4418). May2023, Vol. 13 Issue 10, p1752. 28p.

Relationship of cytochrome P450 gene polymorphisms with blood concentrations of hydroxychloroquine and its metabolites and adverse drug reactions.

Autor: Gao, Beibei¹ (AUTHOR), Tan, Tingfei¹ (AUTHOR), Cao, Xi¹ (AUTHOR), Pan, Menglu² (AUTHOR), Yang, Chunlan¹ (AUTHOR), Wang, Jianxiong² (AUTHOR), Shuai, Zongwen^2,3 (AUTHOR), Xia, Quan^1,4 (AUTHOR) xiaquan2010@163.com

Publikováno v: BMC Medical Genomics. 2/8/2022, Vol. 15 Issue 1, p1-10. 10p.

Hydroxychloroquine-induced Retinal Toxicity.

Autor: Yusuf, Imran H., Issa, Peter Charbel, Seong Joon Ahn

Publikováno v: Frontiers in Pharmacology; 2023, p1-29, 29p